Tag: IPO proceeds

At Nasdaq's opening bell, Kiran Mazumdar-Shaw supported her niece Claire Mazumder as Bicara Therapeutics launched, raising a billion dollars. The Boston firm focuses on innovative therapies for solid tumors, signaling a promising future in cancer treatment.
Posted in Business

Kiran Mazumdar-Shaw’s niece makes debut at Nasdaq with Bicara: ‘Bursting with pride’

 September 27, 2024  Leave a Comment on Kiran Mazumdar-Shaw’s niece makes debut at Nasdaq with Bicara: ‘Bursting with pride’

Sep 27, 2024 12:21 PM IST Kiran Mazumdar-Shaw celebrated her niece Claire Mazumder’s company, Bicara Therapeutics, debuting on Nasdaq. Biocon founder and chairperson Kiran Mazumdar-Shaw’s…

Continue Reading